Skip to content

ALBECESA: sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

ALBECESA

BE 0698.570.838
NACE 86.910, Medical imaging and medical laboratories
NACE division 86, Human health activities all sizesfiscal years 2021 to 202517,899 to 19,634 sector peers per ratio

Summary

fiscal year 2025

ALBECESA does better than half of its sector on 7 of the 7 ratios compared.

most favourable quarter above the median below the median least favourable quarter
Strongest points
  • Return on assetsbetter than 85%
  • Working-capital ratiobetter than 83%
  • Return on equitybetter than 73%
Points to watch

No ratio below the sector median.

    Solvency and debt

    How soundly the company is financed.
    Solvency
    81.6%▲2025

    Solvency is above 71% of 19,634 sector peers: more favourable than the median.

    Position against the sector stable since 2021.

    20212022202320242025
    Debt to equity
    0.23▼2025

    Debt to equity is below 68% of 19,174 sector peers: more favourable than the median.

    Position against the sector stable since 2021.

    20212022202320242025
    Interest coverage
    164.48▲2025

    Interest coverage is above 72% of 18,692 sector peers: more favourable than the median.

    Position against the sector stable since 2021.

    20212022202320242025

    Liquidity

    Whether it can pay its short-term bills.
    Current ratio
    5.46▲2025

    The current ratio is above 70% of 19,341 sector peers: more favourable than the median.

    Position against the sector improving since 2021.

    20212022202320242025
    Working-capital ratio
    81.4%▲2025

    The working-capital ratio is above 83% of 19,608 sector peers: in the most favourable quarter.

    Position against the sector stable since 2021.

    20212022202320242025

    Profitability

    What the company earns on its assets and its sales.
    Return on equity
    61.8%▲2025

    Return on equity is above 73% of 17,899 sector peers: more favourable than the median.

    Position against the sector improving since 2021.

    20212022202320242025
    Return on assets
    50.4%▲2025

    Return on assets is above 85% of 19,601 sector peers: in the most favourable quarter.

    Position against the sector improving since 2021.

    20212022202320242025

    Not computable

    Long-term debt ratio, Net margin, EBITDA margin, Gross margin, Days sales outstanding, Days payable outstanding, Days inventory. This company files the abbreviated or micro schema, in which turnover and purchases are optional; margins and credit terms therefore cannot be taken from its figures.

    Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 28 September 2026 via checked.be.